NBC 4 Report: I-SPY 2 Clinical Trial
I-SPY 2 and Other Platform TrialsПодробнее
Dr. Esserman Discusses the I-SPY 2 TrialПодробнее
Meredith Buxton Discusses the I-SPY 2 TrialПодробнее
I-SPY 2 Clinical Trial for Patients with Stage 2 or 3 Breast CancerПодробнее
Clinical Translational Research Seminar Series: Ari Pelcovits, MD + Patricia Zadnik Sullivan, MDПодробнее
GS4 02 Analysis of clinical outcomes and expression-based immune signatures by race in the I-SPY 2Подробнее
Meredith Buxton on I-SPY 2 Trial for HER2+ Breast CancerПодробнее
Explanatory video about the I-SPY 2 Breast Cancer Clinical TrialПодробнее
Dr. Esserman Discusses the I-SPY 2 Trial in Breast CancerПодробнее
Dr. Esserman on the Elements of the I-SPY 2 Trial in Breast CancerПодробнее
Copy of Dr. Esserman Discusses the I-SPY 2 Trial in Breast CancerПодробнее
i-Spy 2 Press ConferenceПодробнее
I-SPY 2 Segment on NBC Wash DCПодробнее
Dr. Esserman on the Basis for the I-SPY 2 Trial in Breast CancerПодробнее
Paula Pohlmann - Precision medicine in the treatment of patients with breast cancer: I-SPY trialsПодробнее
The CAMBRIA-2 Clinical Trial AnimationПодробнее
Dr. Esserman Gives an Overview of the I-SPY 2 TrialПодробнее
I-SPY 2: advancing outcomes high-risk breast cancer through adapting therapiesПодробнее
Update of I-SPY 2 for Early-Stage Breast CancerПодробнее